A2P.F COPLAND ROAD CAPITAL NEW

Healthcare Pharmaceuticals Frankfurt Exchange
75.10 EUR
Close of Nov 11, 2026
52.56 91.60
Market cap
EUR 641M
P/E
15.4x
P/B
13.09x
ROE
328.2%
Dividend yield
3.44%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is A2P.F undervalued?

Graham number
Price75.10
Graham value25.12
Premium198.9%

A2P.F trades 198.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

COPLAND ROAD CAPITAL NEW fundamental analysis

No fundamental analysis for COPLAND ROAD CAPITAL NEW yet.

COPLAND ROAD CAPITAL NEW stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About COPLAND ROAD CAPITAL NEW

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, it offers maintenance services for medical equipment,…

Full company profile